Vivos (RDGL) Current Leases (2010 - 2025)
Vivos recorded quarterly Current Leases of $25420.0 in Q4 2025, down 35.61% quarter-over-quarter from $39481.0 in Q4 2014.
Vivos' Current Leases history runs 6 years deep, the most recent figure standing at $25420.0 for Q4 2025.
- In Q4 2025, Current Leases changed N/A year-over-year to $25420.0; the TTM figure through Dec 2025 stood at $25420.0 (changed N/A YoY), while the FY2025 annual figure was $25420.0, changed N/A from the prior year.
- Current Leases came in at $25420.0 for Q4 2025 at Vivos, down from $39481.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $25420.0 in Q4 2025 to a low of $25420.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 24.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 20.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 35.80 Mn |
| 10 | Vivos | - | - | -3,105.00 | 25,420.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 25,420.00 |
| Dec 31, 2014 | 39,481.00 |
| Sep 30, 2014 | 109,421.00 |
| Jun 30, 2014 | 177,645.00 |
| Mar 31, 2014 | 244,648.00 |
| Dec 31, 2013 | 309,145.00 |
| Sep 30, 2013 | 264,607.00 |
| Jun 30, 2013 | 175,287.00 |
| Mar 31, 2013 | 319,505.00 |
| Dec 31, 2012 | 346,270.00 |
| Sep 30, 2012 | 366,768.00 |
| Jun 30, 2012 | 815,708.00 |
| Mar 31, 2012 | 925,033.00 |
| Dec 31, 2011 | 427,813.00 |
| Sep 30, 2011 | 425,000.00 |
| Jun 30, 2011 | 417,000.00 |
| Dec 31, 2010 | 405,338.00 |